跳至主要内容
临床试验/SLCTR/2016/012
SLCTR/2016/012尚未招募2 期

A Randomized controlled trial on the safety of ICP-AVRI-UOP Sri Lankan polyspecific antivenom compared to Indian AVS in patients with snakebite

South Asian Clinical Toxicology Research Collaboration0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. History of snake bite with *Daboia russelii* or *Echis carinatus* (by clinical manifestations/visual identification of the snake where possible)
  • 2. Evidence of systemic envenomation based on Ministry of Health/Sri Lanka Medical Association guidelines.

排除标准

  • 1. <14 years of age
  • 2. Pregnancy
  • 3. Already received antivenom, fresh frozen plasma (FFP), or pre-medication such as adrenaline, hydrocortisone or promethazine at the primary hospital
  • 4. History of allergy to antivenom
  • 5. Inability to give direct or proxy consent (unconscious and unaccompanied by a relative)
  • 6. Presentation more than 8 hours after snake bite.

研究者

相似试验